Teva announces it beat out Pfizer in a $5B deal for a privately held generic drug-maker in Germany, with William Marth, Teva Pharmaceutical North America CEO and CNBC's Mike Huckman.
Topics:
Economy (U.S.) | Mergers and Acquisitions | Pharmaceuticals
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT